TY - JOUR
T1 - Melanocyte and keratinocyte carcinogenesis
T2 - p53 family protein activities and intersecting mRNA expression profiles.
AU - Kulesz-Martin, Molly
AU - Lagowski, James
AU - Fei, Suzanne
AU - Pelz, Carl
AU - Sears, Rosalie
AU - Powell, Marianne Broome
AU - Halaban, Ruth
AU - Johnson, Jodi
N1 - Funding Information:
This work was supported by NIH PHS grants to M. K. M. CA98893 and CA106195 Training Grant in Molecular Skin Pathobiology, to the OHSU Cancer Institute CA69533, to M. B. P. CA090897 and CA27502, and to R. H., CA44542, and AR41942 Yale Skin Diseases Research Center. Microarray data analysis and C. P. were supported by an NIH/NCI grant to R. S., K01 CA086957.
PY - 2005/11
Y1 - 2005/11
N2 - Melanocytes and keratinocytes were analyzed for potential roles of p53, p73, and p63 tumor suppressor family proteins and of malignancy-specific gene expression changes in the etiology of multi-step cancer. Melanocytes expressed deltaNp73alpha, two p63 isoforms and p53. Although p21 and Noxa mRNA levels increased following DNA damage, p53 family member binding to p21 and Noxa DNA probes was undetectable, suggesting p53 family-independent responses. In contrast, keratinocytes expressed multiple isoforms each of p73 and p63 that were induced to bind p21 and Noxa DNA probes after ionizing (IR) or after ultraviolet B (UVB) irradiation, correlating with p21 and Noxa mRNA induction and with apoptosis. Interestingly, IR-resistant malignant melanocytes and keratinocytes both exhibited Noxa mRNA induction after UVB treatment, correlating with DNA binding of p53 family proteins to the Noxa probe only in keratinocytes. To uncover other malignancy-specific events, we queried mouse initiated keratinocyte clones for early changes that were exacerbated in malignant derivatives and also differentially expressed in human advanced melanoma versus normal melanocytes. Using a new method for ranking and normalization of microarray data for 5000 probe sets, 27 upregulated and 13 downregulated genes satisfied our query. Of these, the majority was associated with late-stage human cancers and six were novel genes. Thus, clonal lineage mouse models representing early through late cancer progression stages may inform the focus on early, potentially causal events from microarray studies of human cancers, facilitating prognosis and molecular therapy.
AB - Melanocytes and keratinocytes were analyzed for potential roles of p53, p73, and p63 tumor suppressor family proteins and of malignancy-specific gene expression changes in the etiology of multi-step cancer. Melanocytes expressed deltaNp73alpha, two p63 isoforms and p53. Although p21 and Noxa mRNA levels increased following DNA damage, p53 family member binding to p21 and Noxa DNA probes was undetectable, suggesting p53 family-independent responses. In contrast, keratinocytes expressed multiple isoforms each of p73 and p63 that were induced to bind p21 and Noxa DNA probes after ionizing (IR) or after ultraviolet B (UVB) irradiation, correlating with p21 and Noxa mRNA induction and with apoptosis. Interestingly, IR-resistant malignant melanocytes and keratinocytes both exhibited Noxa mRNA induction after UVB treatment, correlating with DNA binding of p53 family proteins to the Noxa probe only in keratinocytes. To uncover other malignancy-specific events, we queried mouse initiated keratinocyte clones for early changes that were exacerbated in malignant derivatives and also differentially expressed in human advanced melanoma versus normal melanocytes. Using a new method for ranking and normalization of microarray data for 5000 probe sets, 27 upregulated and 13 downregulated genes satisfied our query. Of these, the majority was associated with late-stage human cancers and six were novel genes. Thus, clonal lineage mouse models representing early through late cancer progression stages may inform the focus on early, potentially causal events from microarray studies of human cancers, facilitating prognosis and molecular therapy.
UR - http://www.scopus.com/inward/record.url?scp=33644679382&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644679382&partnerID=8YFLogxK
U2 - 10.1111/j.1087-0024.2005.200405.x
DO - 10.1111/j.1087-0024.2005.200405.x
M3 - Article
C2 - 16363065
AN - SCOPUS:33644679382
SN - 1087-0024
VL - 10
SP - 142
EP - 152
JO - Journal of Investigative Dermatology Symposium Proceedings
JF - Journal of Investigative Dermatology Symposium Proceedings
IS - 2
ER -